logo-loader

Verastem Oncology

Receive alerts
Market:
NASDAQ
Market Cap:
$99.63 m
Price
1.34 USD
Change
-1.47%
52 weeks high
4.25
52 weeks low
0.83

In brief

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt.